Evaluation of immunoreactivity of in vitro and in vivo models against bacterial synthesized cellulose to be used as a prosthetic biomaterial

Biochip Journal

Volumn 7, Issue 3, 2013, Pages 201-209

  Kim, Gun Dong ^a   Yang, Hana ^a   Park, Hye Rim ^a   Park, Cheung Seog ^a   Park, Yong Seek ^a   Lee, Seung Eun ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Bacterial cellulose (BC); Biomaterials; Gluconacetobacter xylinus; Human umbilical vein endothelial cells (HUVECs); Immunoreactivity; Lipopolysaccharide (LPS)

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; BIOMATERIALS; CELL DEATH; CELLULOSE; ENDOTHELIAL CELLS; MAMMALS; PROSTHETICS; TENSILE STRENGTH; TISSUE ENGINEERING;

BACTERIAL CELLULOSE; GLUCONACETOBACTER XYLINUS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IMMUNOREACTIVITIES; LIPOPOLYSACCHARIDES;

BIOLOGICAL MATERIALS;

BACTERIAL CELLULOSE; BACTERIUM LIPOPOLYSACCHARIDE; CELLULOSE; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; CARBOHYDRATE SYNTHESIS; CELL SURVIVAL; CONTROLLED STUDY; EXPERIMENTAL MODEL; FLOW CYTOMETRY; GLUCONACETOBACTER XYLINUS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PROSTHESIS MATERIAL; UMBILICAL VEIN ENDOTHELIAL CELL;

BACTERIA (MICROORGANISMS); GLUCONACETOBACTER XYLINUS; MUS;

EID: 84884527599     PISSN: 19760280     EISSN: 20927843     Source Type: Journal    
DOI: 10.1007/s13206-013-7302-9     Document Type: Article

References (40)

1. Petersen, N. & Gatenholm, P. Bacterial cellulose-based materials and medical devices: current state and perspectives. Appl. Microbiol. Biotechnol. 91, 1277-1286 (2011).
2. Klemm, D. et al. Nanocelluloses: A New Family of Nature-Based Materials. Angewandte Chemie-International Edition50, 5438-5466 (2011).
3. Kim, S. Y. et al. Production of bacterial cellulose by Gluconacetobacter sp. RKY5 isolated from persimmon vinegar. Appl. Biochem. Biotechnol. 131, 705-715 (2006).
4. Falcao, S. C., Coelho, A. R. & Evencio Neto, J. Biomechanical evaluation of microbial cellulose (Zoogloea sp.) and expanded polytetrafluoroethylene membranes as implants in repair of produced abdominal wall defects in rats. Acta Cir. Bras. 23, 184-191 (2008).
5. Brown, R. M., Jr., Willison, J. H. & Richardson, C. L. Cellulose biosynthesis in Acetobacter xylinum: visualization of the site of synthesis and direct measurement of the in vivo process. Proc. Natl. Acad. Sci. USA73, 4565-4569 (1976).
6. Ross, P., Mayer, R. & Benziman, M. Cellulose biosynthesis and function in bacteria. Microbiol. Rev. 55, 35-58 (1991).
7. Hutchens, S. A. et al. Biomimetic synthesis of calciumdeficient hydroxyapatite in a natural hydrogel. Biomaterials27, 4661-4670 (2006).
8. Helenius, G. et al. In vivo biocompatibility of bacterial cellulose. J. Biomed. Mater. Res. A. 76, 431-438 (2006).
9. Muller, D. et al. Structure and properties of polypyrrole/bacterial cellulose nanocomposites. Carbohydrate Polymers94, 655-662 (2013).
10. Teeri, T. T., Brumer, H., 3rd, Daniel, G. & Gatenholm, P. Biomimetic engineering of cellulose-based materials. Trends Biotechnol. 25, 299-306 (2007).
11. Czaja, W., Krystynowicz, A., Bielecki, S. & Brown, R. M., Jr. Microbial cellulose - the natural power to heal wounds. Biomaterials27, 145-151 (2006).
12. Liang, Y. et al. A novel bacterial cellulose-based carbon paste electrode and its polyoxometalate-modified properties. Electrochemistry Communications11, 1018-1021 (2009).
13. Jeong, S. I. et al. Effect of alpha, beta-unsaturated aldehydes on endothelial cell growth in bacterial cellulose for vascular tissue engineering. Mol. Cell. Toxicol. 8, 119-126 (2012).
14. Schumann, D. A. et al. Artificial vascular implants from bacterial cellulose: preliminary results of small arterial substitutes. Cellulose16, 877-885 (2009).
15. Klemm, D., Schumann, D., Udhardt, U. & Marsch, S. Bacterial synthesized cellulose - artificial blood vessels for microsurgery. Progress in Polymer Science26, 1561-1603 (2001).
16. Schumann, D. A. et al. New results about BASYC (R) (bacterial synthesized cellulose), the promising artificial blood vessel for microsurgery and further application of bacterial cellulose in medicine. Abstracts of Papers of the American Chemical Society229, U300-U300 (2005).
17. Backdahl, H. et al. Mechanical properties of bacterial cellulose and interactions with smooth muscle cells. Biomaterials27, 2141-2149 (2006).
18. Lau, R. K. L. et al. Mechanical characterization of cellulosic thecal plates in dinoflagellates by nanoindentation. Journal of Nanoscience and Nanotechnology7, 452-457 (2007).
19. Habibovic, P. et al. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials26, 3565-3575 (2005).
20. Fink, H. et al. An in vitro study of blood compatibility of vascular grafts made of bacterial cellulose in comparison with conventionally-used graft materials. Journal of Biomedical Materials Research Part A97A, 52-58 (2011).
21. Wang, B. & Dong, S. Sol-gel-derived amperometric biosensor for hydrogen peroxide based on methylene green incorporated in Nafion film. Talanta51, 565-572 (2000).
22. Salomao, R. et al. Bacterial Sensing, Cell Signaling, and Modulation of the Immune Response during Sepsis. Shock38, 227-242 (2012).
23. Zhao, Q. T., Guo, Q. M., Wang, P. & Wang, Q. Salvianic acid A inhibits lipopolysaccharide-induced apoptosis through regulating glutathione peroxidase activity and malondialdehyde level in vascular endothelial cells. Chinese Journal of Natural Medicines10, 53-57 (2012).
24. Galanos, C. et al. Biological activities of lipopolysaccharides and lipid A from Rhodospirillaceae. Infect. Immun. 16, 407-412 (1977).
25. Mackensen, A., Galanos, C. & Engelhardt, R. Modulating Activity of Interferon-Gamma on Endotoxin-Induced Cytokine Production in Cancer-Patients. Blood78, 3254-3258 (1991).
26. Dimmeler, S. & Zeiher, A. M. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ. Res. 87, 434-439 (2000).
27. Munoz, C. et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. J. Clin. Invest. 88, 1747-1754 (1991).
28. De Beaux, A. C. et al. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release. J. Interferon. Cytokine Res. 15, 441-445 (1995).
29. Le, J., Lin, J. X., Henriksen-DeStefano, D. & Vilcek, J. Bacterial lipopolysaccharide-induced interferongamma production: roles of interleukin 1 and interleukin 2. J. Immunol. 136, 4525-4530 (1986).
30. Eliopoulos, A. G. et al. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21, 4831-4840 (2002).
31. Park, Y. S. et al. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler Thromb Vasc Biol. 27, 1319-1325 (2007).
32. Caughey, G. E. et al. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J. Immunol. 167, 2831-2838 (2001).
33. Tough, D. F., Sun, S. & Sprent, J. T cell stimulation in vivo by lipopolysaccharide (LPS). J. Exp. Med. 185, 2089-2094 (1997).
34. Yang, H. Y., Dundon, P. L., Nahill, S. R. & Welsh, R. M. Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J. Immunol. 142, 1710-1718 (1989).
35. Wang, L. et al. High dose lipopolysaccharide triggers polarization of mouse thymic Th17 cells in vitro in the presence of mature dendritic cells. Cellular Immunology274, 98-108 (2012).
36. O'Sullivan, S. T. et al. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 222, 482-490; discussion 490-482 (1995).
37. Jeong, S. I. et al. Toxicologic evaluation of bacterial synthesized cellulose in endothelial cells and animals. Mol. Cell. Toxicol. 6, 373-380 (2010).
38. Lee, S. E. et al. Upregulation of heme oxygenase-1 as an adaptive mechanism for protection against crotonaldehyde in human umbilical vein endothelial cells. Toxicology Letters201, 240-248 (2011).
39. Jeong, S. I. et al. Genome-wide analysis of gene expression by crotonaldehyde in human umbilical vein endothelial cells. Mol. Cell. Toxicol. 7, 127-134 (2011).
40. Yang, H. et al. Up-regulation of Heme Oxygenase-1 by Korean Red Ginseng Water Extract as a Cytoprotective Effect in Human Endothelial Cells. Journal of Ginseng Research35, 352-359 (2011).